Search results
Results From The WOW.Com Content Network
MRSA is responsible for several difficult-to-treat infections in humans. It caused more than 100,000 deaths worldwide attributable to antimicrobial resistance in 2019. MRSA is any strain of S. aureus that has developed (through natural selection) or acquired (through horizontal gene transfer) a multiple drug resistance to beta-lactam antibiotics.
The anterior nares can act as a colonizing point from which the infection can spread. [2] This can be particularly troublesome if the strain is an antibiotic-resistant (commonly MRSA or ORSA) strain. MRSA (first discovered in the UK in 1961) has become particularly widespread in hospitals and is commonly considered a super bug.
Now, methicillin-resistant Staphylococcus aureus (MRSA) is not only a human pathogen causing a variety of infections, such as skin and soft tissue infection (SSTI), pneumonia, and sepsis, but it also can cause disease in animals, known as livestock-associated MRSA (LA-MRSA). [116]
Vancomycin for Methicillin-resistant (MRSA) [33] (no vaccine or preventive drug) Barrier precautions, washing hands and fomite disinfection in hospitals; epidermidis: Human flora in skin, [33] [48] anterior nares [33] and mucous membranes [48] Infections of implanted prostheses (e.g. heart valves [33] and joints [48]) and catheters [33] [48 ...
The infection can be life-threatening. Problematically, methicillin-resistant Staphylococcus aureus (MRSA) has become a major cause of hospital-acquired infections. MRSA has also been recognized with increasing frequency in community-acquired infections. [7]
One of the most commonly known examples of both antimicrobial resistance and the relationship to the classification of a drug of last resort is the emergence of Staphylococcus aureus (MRSA) (sometimes also referred to as multiple-drug resistant S. aureus due to resistance to non-penicillin antibiotics that some strains of S. aureus have shown ...
Because of the calendar, Social Security recipients who get Supplemental Security Income benefits get their first 2025 check on Dec. 31, 2024.
Bactroban is, I think, more commonly used to reduce nasal carriage of MRSA, usually in hospital or nursing home staff, but certainly Bacitracin is also used. This isn't treatment of an infection: it's a means of reducing colonization of the nares in order to prevent spread to individuals likely to develop infection.